Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Febuxostat × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 516 Specimen Handling 372 Carboplatin 365 Magnetic Resonance Spectroscopy 323 Cisplatin 315 Nivolumab 306 Cyclophosphamide 294 Paclitaxel 251 Radiotherapy 250 Biopsy 228 Gemcitabine 219 Bevacizumab 211 Dexamethasone 172 durvalumab 164 Rituximab 159 Oxaliplatin 154 Capecitabine 153 venetoclax 150 Fluorouracil 149 atezolizumab 143 Docetaxel 142 Drug Therapy 139 Etoposide 133 Ipilimumab 132 Doxorubicin 131 Prednisone 122 Radiosurgery 120 Lenalidomide 120 Leucovorin 110 Pemetrexed 107

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07485452 2026-03-20

OSIBBBOOST

Maastricht University Medical Center

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡